Can Ozempic-Like Drugs Help Combat Dementia?

Quick Summary

• Neuroscientists like Yazhou Li at the National Institute of Aging are researching GLP-1 agonist drugs-like Ozempic and Wegovy-to address dementia, brain injuries, Alzheimer’s disease, and Parkinson’s.
• These drugs,originally developed for diabetes and weight loss,appear to reduce brain inflammation and improve cognition in animal models.
• Insulin resistance in the brain is linked to neurodegenerative diseases such as Alzheimer’s. These drugs may aid by improving insulin signaling or reducing inflammation.
• Clinical studies indicate GLP-1 agonists provide measurable cognitive benefits for diabetes patients; results for non-diabetic populations are mixed or unclear.
• Long-term effects of GLP-1 agonists remain unknown; concerns include side effects like nausea and pancreatitis.
• Scientists caution against premature use due to insufficient evidence of broad benefits for healthy individuals.

!Read More